TRIMTECH has a growing pipeline of potent, CNS (central nervous system) penetrant therapeutics based on its aggregate-selective degrader molecules known as TRIMTACs and TRIMGLUEs. The pipeline is focused around the development of treatments for severe neurodegenerative and inflammatory disorders, including Alzheimer’s and Huntington’s disease.
Company Details
- Employees
- 15
- Founded
- 2023
- Address
- Some Of The Most Challenging Neurodegenerative And Inflammatory Diseases.
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://trimtechtherapeutics.com
- Keywords
- Technician jobs.
Trimtech Therapeutics Limited Questions
Trimtech Therapeutics Limited's website is https://trimtechtherapeutics.com
Trimtech Therapeutics Limited's LinkedIn profile is https://www.linkedin.com/company/trimtech-therapeutics-limited
Trimtech Therapeutics Limited has
15 employees.
View email and phone details for 15
employees at Trimtech Therapeutics Limited.
Trimtech Therapeutics Limited's industry is
Biotechnology Research
Trimtech Therapeutics Limited's top competitors are
Apollo Therapeutics,
Verdiva Bio,
Zygosity,
Crescendo Biologics Limited,
Ignota Labs,
Astronautx,
Clock.bio,
Amphista Therapeutics Limited,
Isomorphic Labs,
Maxion Therapeutics.
Trimtech Therapeutics Limited's categories are Biotechnology Research
Trimtech Therapeutics Limited's founding year is 2023
